Beneficial effects of combined blockade of ACE and AT1 receptor on intimal hyperplasia in balloon-injured rat artery

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 8, 2002, Pages 1299-1304

  Kim, Shokei ^a   Izumi, Yasukatsu ^a   Izumiya, Yasuhiro ^a   Zhan, Yumei ^a   Taniguchi, Masaru ^a   Iwao, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Angiotensin converting enzyme; Balloon injury; Combination therapy; Intimal thickening

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FR 172357; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; OLMESARTAN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TEMOCAPRIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIES; BLOOD PRESSURE; CELL DIVISION; CREATININE; HYPERPLASIA; IMIDAZOLES; MALE; NG-NITROARGININE METHYL ESTER; PHOSPHORYLATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, ANGIOTENSIN; TETRAZOLES; THIAZEPINES; TIME FACTORS; TUNICA INTIMA; TYROSINE;

EID: 0036341147     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000026298.00663.58     Document Type: Article

References (34)

1. Molecular mechanism of vascular renin-angiotensin system in myointimal hyperplasia
2. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases
3. Angiotensin II receptors and angiotensin II receptor antagonists
4. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
5. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation
6. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: Effects on smooth muscle cell migration and proliferation after balloon catheter injury
7. Angiotensin II type I receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery
8. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty?: Results of the MERCATOR Study: A multicenter, randomized, double-blind placebo-controlled trial
9. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
10. Cardiovascular effects of combination of perindopril, candesartan and amlodipine in hypertensive rats
11. Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism
12. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function and survival in rat heart failure
13. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
14. Additive effects of losartan and enalapril on blood pressure and plasma active renin
15. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
16. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study: The RESOLVD Pilot Study Investigators
17. Effects of angiotensin AT1 receptor antagonist on volume overload-induced cardiac gene expression in rats
18. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
19. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension
20. Pharmacological profiles of CS-622, a novel angiotensin converting enzyme inhibitor
21. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657
22. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997
23. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
24. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells
25. In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension
26. Mechanisms of angiotensin II formation in humans
27. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
28. Mechanism of action and in vivo role of platelet-derived growth factor
29. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty
30. The pathogenesis of atherosclerosis: A perspective for the 1990s
31. PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery
32. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
33. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: A link between angiotensin II and intimal thickening
34. Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaC1 intake